The LIMIT chip is a platform technology to allow drug researcher to conduct high throughput screens for lipophilic and hydrophobic drugs. The initial customers will be academic researchers/labs, small pharmaceutical companies, CRO's, and later drug discovery/development companies. Lipid Nanotech has an innovative microarray nanotechnology that can conduct 50,000 drug tests on one plate (high-throughput screen). The current industry standard is only able to conduct 1,500 drug tests per plate. Our technology uses a fraction of the cells and consumables, and operates at fractions of the cost. It costs Pharma companies roughly $1,000,000 to screen 1 million drugs. Lipid Nanotech is able to screen 1 million drugs at a cost of roughly $20,000 USD. Our technology captures the largest market share (40% - High-throughput screening market) of Global drug discovery technologies $46.5 billion dollar market (2014) with a CAGR of 11.3%.